Anxiety sensitivity as a transdiagnostic risk factor for trajectories of adverse posttraumatic neuropsychiatric sequelae in the AURORA study
Short NA, van Rooij SJH, Murty VP, Stevens JS, An X, Ji Y, McLean SA, House SL, Beaudoin FL, Zeng D, Neylan TC, Clifford GD, Linnstaedt SD, Germine LT, Bollen KA, Rauch SL, Haran JP, Lewandowski C, Musey PI, Hendry PL, Sheikh S, Jones CW, Punches BE, Swor RA, McGrath ME, Hudak LA, Pascual JL, Seamon MJ, Datner EM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O'Neil BJ, Sergot P, Sanchez LD, Bruce SE, Pietrzak RH, Joormann J, Barch DM, Pizzagalli DA, Sheridan JF, Smoller JW, Harte SE, Elliott JM, Kessler RC, Koenen KC, Jovanovic T. Anxiety sensitivity as a transdiagnostic risk factor for trajectories of adverse posttraumatic neuropsychiatric sequelae in the AURORA study. Journal Of Psychiatric Research 2022, 156: 45-54. PMID: 36242943, PMCID: PMC10960961, DOI: 10.1016/j.jpsychires.2022.09.027.Peer-Reviewed Original ResearchConceptsAdverse posttraumatic neuropsychiatric sequelaeAnxiety sensitivityTransdiagnostic risk factorWeeks posttraumaPersistent trajectoryPersistent posttraumatic stressElevated anxiety sensitivityTrauma-related symptomsPosttraumatic stress disorderTrauma-related pathologySelf-report assessmentsNeuropsychiatric sequelaeAURORA studyPersonality-related factorsSleep disturbancesGrowth mixture modelingAnxious arousalPosttraumatic stressTrauma survivorsStress disorderBrief interventionPosttrauma periodSomatic symptomsMixture modelingPosttraumaPredicting at-risk opioid use three months after ed visit for trauma: Results from the AURORA study
Punches BE, Stolz U, Freiermuth CE, Ancona RM, McLean SA, House SL, Beaudoin FL, An X, Stevens JS, Zeng D, Neylan TC, Clifford GD, Jovanovic T, Linnstaedt SD, Germine LT, Bollen KA, Rauch SL, Haran JP, Storrow AB, Lewandowski C, Musey PI, Hendry PL, Sheikh S, Jones CW, Kurz MC, Gentile NT, McGrath ME, Hudak LA, Pascual JL, Seamon MJ, Harris E, Chang AM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O’Neil B, Sanchez LD, Bruce SE, Pietrzak RH, Joormann J, Barch DM, Pizzagalli DA, Smoller JW, Luna B, Harte SE, Elliott JM, Kessler RC, Ressler KJ, Koenen KC, Lyons MS. Predicting at-risk opioid use three months after ed visit for trauma: Results from the AURORA study. PLOS ONE 2022, 17: e0273378. PMID: 36149896, PMCID: PMC9506640, DOI: 10.1371/journal.pone.0273378.Peer-Reviewed Original ResearchMeSH KeywordsAcute PainAdultAnalgesics, OpioidEmergency Service, HospitalHumansOpioid-Related DisordersPractice Patterns, Physicians'Prospective StudiesConceptsOpioid analgesic exposuresNon-medical opioid useOpioid useAnalgesic exposureOpioid exposureOpioid prescriptionsED opioid administrationED opioid prescriptionInitial ED encounterSubsequent opioid useAdult trauma patientsProspective cohort studyPrescription opioid useMultivariable logistic regressionED administrationED opioidsED prescriptionPain leadOpioid administrationAdult patientsCohort studyED visitsClinical factorsED encountersHospital admission